No weight loss on Mounjaro: the most common reasons and what actually helps

Step 1, Understand what the first few weeks are actually for

The 2.5mg starting dose is not a therapeutic dose in the conventional sense. Its job is to let your body adapt to tirzepatide, keeping nausea and other gastrointestinal side effects manageable as the medicine beds in. Most people on this dose notice appetite changes but little movement on the scale, and that is expected, not a sign the treatment isn't working.

Week-by-week accounts from the very first week through to week three consistently show the same pattern: appetite shifts before weight does. The scale often lags by one to two weeks. If you want a realistic picture of the timeline, how long Mounjaro typically takes to work sets out what the trial data actually shows across the full dosing schedule.

One thing worth knowing: body composition can be changing while body weight holds still. Water retention (especially around the time of a dose increase or a hormonal cycle) can fully offset several hundred grams of genuine fat loss. The scale is one signal among several, not the whole story.

Step 2, Check the factors that commonly blunt the response

A flat line on the scale at any point after the first few weeks usually has one or more identifiable reasons. The most common ones, according to clinical evidence and what prescribers observe, fall into a short list.

Calorie compensation. Tirzepatide reduces appetite, it does not remove the effect of calorie-dense foods entirely. If smaller portions are replaced by more calorie-dense choices, or if alcohol intake has increased, total intake may not fall as much as expected. Keeping a rough food diary for a week or two often surfaces patterns that aren't obvious in the moment.

Dose still too low. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded average weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks. Participants on lower doses lost considerably less. If you are still on 2.5mg or 5mg, you may simply not yet be at the dose where the medicine has its full effect. Titration decisions belong with your prescriber.

Muscle gain obscuring fat loss. Resistance exercise, which is recommended alongside treatment, adds muscle mass that weighs more than the fat it displaces. Waist measurement and how clothes fit are often more informative than weight alone during the early months. You can read about how weight loss on Mounjaro typically unfolds to set expectations against the evidence.

Plateau after initial loss. A period of no change after good early results is a recognised biological response. The body adjusts its metabolic rate as weight falls. This is not treatment failure; it usually responds to a dose review or a targeted dietary adjustment discussed with a prescriber. There is a separate discussion of what happens when Mounjaro stops working as well as it did if that matches where you are.

Step 3, Know when to raise it with a prescriber

Not every flat spell needs clinical attention straight away. Week two of 2.5mg is normal. Week four of 2.5mg is still within a predictable range, what to expect at week four covers this in detail. But there are situations that do warrant a clinical conversation.

NICE's appraisal of tirzepatide (TA1026) sets a clear marker: if weight loss is less than 5% after six months at the highest dose you can tolerate, continuing treatment should be clinically reviewed. That is the published threshold. Before that point, a prescriber can assess whether the titration schedule is right, whether any medicines you take alongside Mounjaro are affecting the response, and whether there are underlying factors (thyroid function, for example) that have not been ruled out.

Oral contraceptive pill users should note that tirzepatide slows gastric emptying, which can reduce pill absorption in the first four weeks of treatment and for four weeks after each dose increase. A non-oral method during those windows is the guidance from NHS England. This is worth raising with your prescriber if it applies to you.

For people transferring from another GLP-1 medicine, or for those wondering whether to compare options, the full Mounjaro overview and our clinical team's details at our prescriber profile page are good starting points. You can also review how Mounjaro private treatment is priced in the UK if cost is part of the consideration.

At nume, every repeat order goes back to a GPhC-registered prescriber, a real clinician reads your update before anything is dispensed, which means if your response has stalled, that is exactly the moment the clinical review can flag it. Your pen arrives from our pharmacy via DPD the next working day, in plain packaging, once approved. If you have questions before or between orders, our support team is available seven days a week. If you're ready to start, or to review a stalled plan with a prescriber, start your free consultation and a prescriber will review your case the same day.